3-iodobenzylguanidine has been researched along with Diabetes Mellitus, Type 1 in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.76) | 18.7374 |
| 1990's | 14 (66.67) | 18.2507 |
| 2000's | 4 (19.05) | 29.6817 |
| 2010's | 2 (9.52) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amanullah, A; Ananthasubramaniam, K; Caldwell, JH; Clements, IP; Gerson, MC; Henzlova, MJ; Jacobson, AF | 1 |
| Hage, FG; Iskandrian, AE | 1 |
| Bengel, FM; Hattori, N; Nekolla, SG; Rihl, J; Schnell, O; Schwaiger, M; Standl, E | 1 |
| Antonelli Incalzi, R; Basso, S; Calcagni, ML; Fuso, L; Ghirlanda, G; Giordano, A; Longobardi, A; Pitocco, D; Trové, A | 1 |
| Dudczak, R; Edlmayer, A; Fasching, P; Korn, A; Kreiner, G; Leitha, T; Waldhäusl, W; Wolzt, M | 1 |
| Brunhölzl, C; Claus, D; Feistel, H; Neundörfer, B; Platsch, G; Wolf, F | 1 |
| Haslbeck, M; Kirsch, CM; Schnell, O; Standl, E; Stemplinger, J | 1 |
| Hozumi, T; Ishida, Y; Kasuga, M; Kazumi, T; Matsunaga, K; Shiotani, H; Ueno, H; Yoshida, R | 1 |
| Dresel, S; Haslbeck, M; Muhr, D; Schnell, O; Standl, E; Weiss, M | 2 |
| Ahonen, A; Airaksinen, KE; Heikkila, J; Huikuri, HV; Koistinen, MJ; Linnaluoto, MM; Torniainen, P | 1 |
| Dresel, S; Haslbeck, M; Muhr, D; Schsnell, O; Standl, E; Tatsch, K; Ziegler, AG | 1 |
| Kuikka, JT; Turpeinen, AK; Uusitupa, MI; Vanninen, E | 1 |
| Boy, C; Gries, FA; Hübinger, A; Langen, KJ; Müller-Gärtner, HW; Piolot, R; Weise, F; Ziegler, D | 2 |
| Avogaro, A; Casara, D; Crepaldi, C; Dalla Volta, S; Erle, G; Fasoli, G; Marin, M; Mingardi, R; Palisi, M; Scognamiglio, R | 1 |
| Becerra García, D; Escobar Jiménez, F; Fernández Fernández, B; Fernández Soto, M; Lumbreras Vega, L; Martínez Sampere, JJ; Nevado Jiménez, A; Nieto Serrano, R | 1 |
| Muhr-Becker, D; Schnell, O; Standl, E; Tatsch, K; Weiss, M; Wolfram, G | 1 |
| Avogaro, A; Casara, D; Scognamiglio, R | 1 |
| Antonelli Incalzi, R; Calcagni, ML; Fuso, L; Ghirlanda, G; Giordano, A; Maiolo, C; Pitocco, D | 1 |
| Kahn, JK; Sisson, JC; Vinik, AI | 1 |
1 trial(s) available for 3-iodobenzylguanidine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Investigation of parasympathetic and sympathetic cardiac innervation in diabetic neuropathy: heart rate variation versus meta-iodo-benzylguanidine measured by single photon emission computed tomography.
Topics: 3-Iodobenzylguanidine; Adult; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Female; Heart; Heart Conduction System; Heart Rate; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Parasympathetic Nervous System; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1994 |
20 other study(ies) available for 3-iodobenzylguanidine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Influence of diabetes mellitus on prognostic utility of imaging of myocardial sympathetic innervation in heart failure patients.
Topics: 3-Iodobenzylguanidine; Aged; Chi-Square Distribution; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Female; Heart; Heart Failure; Humans; Male; Middle Aged; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2011 |
Cardiac autonomic denervation in diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Disease Progression; Heart; Heart Failure; Humans; Predictive Value of Tests; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Sympathetic Nervous System; Time Factors; Ventricular Function, Left | 2011 |
Cardiac autonomic dysinnervation and myocardial blood flow in long-term Type 1 diabetic patients.
Topics: 3-Iodobenzylguanidine; Deferoxamine; Diabetes Mellitus, Type 1; Female; Heart; Humans; Iron Chelating Agents; Male; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals | 2003 |
Decline of neuroadrenergic bronchial innervation and respiratory function in type 1 diabetes mellitus: a longitudinal study.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Carbon Monoxide; Diabetes Mellitus, Type 1; Female; Forced Expiratory Volume; Glycated Hemoglobin; Humans; Longitudinal Studies; Lung; Male; Middle Aged; Pulmonary Diffusing Capacity; Radionuclide Imaging; Radiopharmaceuticals; Respiration; Sympathetic Nervous System; Vital Capacity | 2007 |
Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Heart; Heart Function Tests; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Radionuclide Imaging; Reflex; Ventricular Function, Left | 1995 |
Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Electrocardiography; Female; Heart Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Radionuclide Imaging; Sympathetic Nervous System | 1995 |
Cardiac sympathetic nervous dysfunction in mitochondrial cardiomyopathy and diabetes.
Topics: 3-Iodobenzylguanidine; Adult; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Mitochondria, Heart; Point Mutation; Radionuclide Imaging; RNA; RNA, Mitochondrial; RNA, Transfer, Leu; Thallium Radioisotopes | 1995 |
Reduced myocardial 123I-metaiodobenzylguanidine uptake in newly diagnosed IDDM patients.
Topics: 3-Iodobenzylguanidine; Adult; Blood Glucose; Contrast Media; Diabetes Mellitus, Type 1; Female; Heart; Heart Rate; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Myocardium; Radionuclide Imaging; Respiration; Systole; Technetium Tc 99m Sestamibi; Valsalva Maneuver | 1996 |
No difference in cardiac innervation of diabetic patients with painful and asymptomatic coronary artery disease.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Coronary Disease; Denervation; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Electroencephalography; Exercise Test; Female; Follow-Up Studies; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Myocardial Ischemia; Pain; Radiography; Radionuclide Imaging | 1996 |
Autoantibodies against sympathetic ganglia and evidence of cardiac sympathetic dysinnervation in newly diagnosed and long-term IDDM patients.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Autoantibodies; Autonomic Nervous System Diseases; Cohort Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Electrocardiography; Female; Ganglia, Sympathetic; Heart; Heart Diseases; Humans; Iodine Radioisotopes; Iodobenzenes; Islets of Langerhans; Male; Middle Aged; Myocardium; Sympatholytics; Tomography, Emission-Computed, Single-Photon | 1996 |
Demonstration of regional sympathetic denervation of the heart in diabetes. Comparison between patients with NIDDM and IDDM.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Autonomic Nervous System; Blood Pressure; Contrast Media; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Echocardiography; Epinephrine; Female; Heart; Heart Rate; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Middle Aged; Muscle Denervation; Norepinephrine; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon | 1996 |
Partial restoration of scintigraphically assessed cardiac sympathetic denervation in newly diagnosed patients with insulin-dependent (type 1) diabetes mellitus at one-year follow-up.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Electrocardiography; Female; Follow-Up Studies; Heart; Humans; Hypoglycemic Agents; Insulin; Iodine Radioisotopes; Iodobenzenes; Male; Myocardium; Sympathetic Nervous System; Tomography, Emission-Computed, Single-Photon | 1997 |
Evaluation of QT interval length, QT dispersion and myocardial m-iodobenzylguanidine uptake in insulin-dependent diabetic patients with and without autonomic neuropathy.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Electrocardiography; Female; Heart; Heart Function Tests; Heart Rate; Humans; Iodine Radioisotopes; Male; Middle Aged; Signal Processing, Computer-Assisted; Tomography, Emission-Computed, Single-Photon | 1997 |
Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adrenergic beta-Agonists; Adrenergic Fibers; Adult; Body Weight; Cardiac Complexes, Premature; Cardiac Output, Low; Cardiac Volume; Cardiomyopathies; Case-Control Studies; Diabetes Mellitus, Type 1; Dobutamine; Echocardiography; Electric Stimulation; Exercise; Female; Hand Strength; Heart Conduction System; Humans; Incidence; Linear Models; Male; Myocardial Contraction; Physical Exertion; Radionuclide Imaging; Radiopharmaceuticals; Rest; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Function, Left | 1998 |
[Evaluation of cardiac sympathetic innervation with 123I-metaiodobenzylguanidine in patients with diabetes mellitus].
Topics: 3-Iodobenzylguanidine; Adult; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Heart; Humans; Male; Peripheral Nervous System Diseases; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System | 1998 |
Effect of glycaemic control on myocardial sympathetic innervation assessed by [123I]metaiodobenzylguanidine scintigraphy: a 4-year prospective study in IDDM patients.
Topics: 3-Iodobenzylguanidine; Adult; Aged; Biomarkers; Blood Glucose; Blood Pressure; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Diabetic Retinopathy; Electrocardiography; Female; Glycated Hemoglobin; Heart; Heart Rate; Humans; Long QT Syndrome; Male; Middle Aged; Peripheral Nerves; Radionuclide Imaging; Radiopharmaceuticals; Reference Values; Sympathetic Nervous System; Ventricular Function, Left | 1998 |
Scintigraphically assessed cardiac sympathetic dysinnervation in poorly controlled type 1 diabetes mellitus: one-year follow-up with improved metabolic control.
Topics: 3-Iodobenzylguanidine; Adolescent; Adult; Albuminuria; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Follow-Up Studies; Heart; Humans; Radionuclide Imaging; Radiopharmaceuticals; Sympathetic Nervous System; Technetium Tc 99m Sestamibi | 1999 |
Myocardial dysfunction and adrenergic innervation in patients with Type 1 diabetes mellitus.
Topics: 3-Iodobenzylguanidine; Adrenergic Fibers; Adult; Cardiac Output; Cardiac Volume; Cardiomyopathies; Cohort Studies; Diabetes Mellitus, Type 1; Echocardiography; Exercise; Female; Hand Strength; Humans; Male; Radionuclide Imaging; Ventricular Dysfunction, Left; Ventricular Function | 2000 |
Neuroadrenergic denervation of the lung in type I diabetes mellitus complicated by autonomic neuropathy.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Bronchi; Diabetes Mellitus, Type 1; Female; Humans; Lung; Male; Middle Aged; Pentetic Acid; Radiopharmaceuticals | 2002 |
Prediction of sudden cardiac death in diabetic autonomic neuropathy.
Topics: 3-Iodobenzylguanidine; Adult; Autonomic Nervous System Diseases; Death, Sudden; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Electrocardiography; Heart; Humans; Iodine Radioisotopes; Iodobenzenes; Male; Radionuclide Imaging | 1988 |